Anders Dahlén

Director, Oligo Chemistry Team at AstraZeneca

About

Links

Timeline

  • Director, Oligo Chemistry Team

    May, 2020 - present

  • Team Leader, New Modalities Chemistry, IMED CVRM

    April, 2018

  • Interim Team Leader, New Modalities Peptide Team

    September, 2017

  • Team Leader, New Modalities RNA Team

    February, 2016

  • International Assignment In The Chemical Biology Section Of Chemistry Innovation Centre

    February, 2015

  • New Modalities Chemist

    July, 2013

  • Associate Principal Scientist

    May, 2012

  • Senior Research Scientist

    October, 2005